RSM has again submitted a comment letter to U.S. congressional leaders requesting that they quickly address new, problematic requirements to capitalize and amortize research and experimental expenditures, as defined under section 174 of the Internal Revenue Code, in accordance with the Tax Cuts and Jobs Act as enacted in 2017.
RSM has called for Congress to reinstate immediate expensing of qualifying research and experimental costs under section 174, rather than recently enacted requirements to amortize and capitalize expenses over five or 15 years.
